{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:52:31Z","timestamp":1791204751942,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360529"],"award-info":[{"award-number":["82360529"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bbadis.2026.168232","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T12:52:36Z","timestamp":1775047956000},"page":"168232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["USP47 alleviates metabolic-associated fatty liver disease by activating the PPAR\u03b1 signaling pathway through the stabilization of SIRT1"],"prefix":"10.1016","volume":"1872","author":[{"given":"Ya","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengrong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huangyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongqiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bbadis.2026.168232_bb0005","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bbadis.2026.168232_bb0010","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2026.168232_bb0015","doi-asserted-by":"crossref","DOI":"10.1177\/20420188241242937","article-title":"Gut microbiota in MAFLD: therapeutic and diagnostic implications","volume":"15","author":"Alghamdi","year":"2024","journal-title":"Ther. Adv. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168232_bb0020","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s13105-023-00954-4","article-title":"Metabolic dysfunction-associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment","volume":"79","author":"Sangro","year":"2023","journal-title":"J. Physiol. Biochem."},{"issue":"11","key":"10.1016\/j.bbadis.2026.168232_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25115640","article-title":"Metabolic dysfunction-associated steatotic liver disease: from pathogenesis to current therapeutic options","volume":"25","author":"Portincasa","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168232_bb0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrd.2017.152","article-title":"Deubiquitylating enzymes and drug discovery: emerging opportunities","volume":"17","author":"Harrigan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168232_bb0035","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41580-019-0099-1","article-title":"Breaking the chains: deubiquitylating enzyme specificity begets function","volume":"20","author":"Clague","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.bbadis.2026.168232_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2025.120021","article-title":"Deubiquitinases in metabolic diseases, fibrosis and cancer of the liver","volume":"1872","author":"Thakur","year":"2025","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168232_bb0045","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1002\/hep.29375","article-title":"USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity","volume":"66","author":"An","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2026.168232_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.726632","article-title":"Role of ubiquitin-specific peptidase 47 in cancers and other diseases","volume":"9","author":"Pan","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbadis.2026.168232_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115024","article-title":"Targeting USP47 enhances immunotherapy in hepatocellular carcinoma by destabilizing PD-L1","volume":"161","author":"Jiang","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.bbadis.2026.168232_bb0060","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1007\/s11427-021-2040-8","article-title":"Ubiquitin-specific protease 47 regulates intestinal inflammation through deubiquitination of TRAF6 in epithelial cells","volume":"65","author":"Lei","year":"2022","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.bbadis.2026.168232_bb0065","article-title":"Regulation of SIRT1 and its roles in inflammation","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2026.168232_bb0070","article-title":"Berberine alleviates nonalcoholic hepatic steatosis partially by promoting SIRT1 deacetylation of CPT1A in mice","volume":"11","author":"Wang","year":"2023","journal-title":"Gastroenterol. Rep."},{"key":"10.1016\/j.bbadis.2026.168232_bb0075","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/DMSO.S232279","article-title":"DHA protects against hepatic steatosis by activating Sirt1 in a high fat diet-induced nonalcoholic fatty liver disease mouse model","volume":"13","author":"Luo","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes. Targets Ther."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168232_bb0080","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1038\/s41598-017-02416-6","article-title":"Scopolin ameliorates high-fat diet induced hepatic steatosis in mice: potential involvement of SIRT1-mediated signaling cascades in the liver","volume":"7","author":"Yoo","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168232_bb0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12944-023-01798-z","article-title":"Exercise activates Sirt1-mediated Drp1 acetylation and inhibits hepatocyte apoptosis to improve nonalcoholic fatty liver disease","volume":"22","author":"Hu","year":"2023","journal-title":"Lipids Health Dis."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168232_bb0090","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.14431","article-title":"Icariin promotes osteogenic differentiation of human bone marrow mesenchymal stem cells by regulating USP47\/SIRT1\/Wnt\/\u03b2-catenin","volume":"103","author":"Wang","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"issue":"11","key":"10.1016\/j.bbadis.2026.168232_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/biom14111445","article-title":"Exploring PPAR gamma and PPAR alpha\u2019s regulation role in metabolism via epigenetics mechanism","volume":"14","author":"Ma\u0142odobra-Mazur","year":"2024","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.bbadis.2026.168232_bb0100","first-page":"333","article-title":"Resveratrol reduces lipid accumulation through upregulating the expression of microRNAs Regulating fatty acid bet oxidation in liver cells: evidence from in vivo and in vitro studies","volume":"19","author":"Koushki","year":"2020","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.bbadis.2026.168232_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1074911","article-title":"PPAR\u03b1: n emerging target of metabolic syndrome, neurodegenerative and cardiovascular diseases","volume":"13","author":"Lin","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"26","key":"10.1016\/j.bbadis.2026.168232_bb0110","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.3748\/wjg.v29.i26.4136","article-title":"Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas","volume":"29","author":"Souza-Tavares","year":"2023","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168232_bb0115","doi-asserted-by":"crossref","first-page":"8177","DOI":"10.1038\/s41598-021-87759-x","article-title":"SIRT1 promotes lipid metabolism and mitochondrial biogenesis in adipocytes and coordinates adipogenesis by targeting key enzymatic pathways","volume":"11","author":"Majeed","year":"2021","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168232_bb0120","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cmet.2009.02.006","article-title":"Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation","volume":"9","author":"Purushotham","year":"2009","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2026.168232_bb0125","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.biopha.2018.09.089","article-title":"Effect of silibinin on CFLAR-JNK pathway in oleic acid-treated HepG2 cells","volume":"108","author":"Liu","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168232_bb0130","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1186\/s12967-023-04790-4","article-title":"Didymin alleviates metabolic dysfunction-associated fatty liver disease (MAFLD) via the stimulation of Sirt1-mediated lipophagy and mitochondrial biogenesis","volume":"21","author":"Yang","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbadis.2026.168232_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.831879","article-title":"Hepatic PPAR\u03b1 is destabilized by SIRT1 deacetylase in undernourished male mice","volume":"9","author":"Suh","year":"2022","journal-title":"Front. Nutr."},{"issue":"12","key":"10.1016\/j.bbadis.2026.168232_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/metabo14120692","article-title":"Long-term aerobic exercise enhances hepatoprotection in MAFLD by modulating exosomal miR-324 via ROCK1","volume":"14","author":"Zhang","year":"2024","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168232_bb0145","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000535524","article-title":"Mechanisms and therapeutic strategies for MAFLD targeting TLR4 signaling pathways","volume":"16","author":"Ren","year":"2024","journal-title":"J. Innate Immun."},{"issue":"Pt 1","key":"10.1016\/j.bbadis.2026.168232_bb0150","article-title":"The diverse functions of ubiquitin-specific protease 47 and its role in diseases","volume":"328","author":"Lei","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168232_bb0155","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/FJC.0000000000001640","article-title":"Deubiquitinase USP47 ameliorates cardiac hypertrophy through reducing protein O-GlcNAcylation","volume":"85","author":"Jiang","year":"2025","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bbadis.2026.168232_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121967","article-title":"Ubiquitin specific peptidase 47 contributes to liver regeneration","volume":"329","author":"Zhu","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2026.168232_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2016.12.010","article-title":"Salvianolic acid B protects against chronic alcoholic liver injury via SIRT1-mediated inhibition of CRP and ChREBP in rats","volume":"267","author":"Zhang","year":"2017","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168232_bb0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12876-025-03632-5","article-title":"Neuregulin1 ameliorates metabolic dysfunction-associated fatty liver disease via the ERK\/SIRT1 signaling pathways","volume":"25","author":"Xu","year":"2025","journal-title":"BMC Gastroenterol."},{"issue":"21","key":"10.1016\/j.bbadis.2026.168232_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e39890","article-title":"Lactucin ameliorates FFA-induced steatosis in HepG2 cells by modulating mitochondrial homeostasis through the SIRT1\/PGC-1\u03b1 signaling axis","volume":"10","author":"Lei","year":"2024","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.bbadis.2026.168232_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.70022","article-title":"HLF and PPAR\u03b1 axis regulates metabolic-associated fatty liver disease through extracellular vesicles derived from the intestinal microbiota","volume":"4","author":"Yang","year":"2025","journal-title":"iMeta"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168232_bb0185","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13578-025-01364-3","article-title":"Enpp1 ameliorates MAFLD by regulating hepatocyte lipid metabolism through the AMPK\/PPAR\u03b1 signaling pathway","volume":"15","author":"Liu","year":"2025","journal-title":"Cell Biosci."},{"issue":"11","key":"10.1016\/j.bbadis.2026.168232_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107876","article-title":"Ubiquitin-specific peptidase 25 ameliorates hepatic steatosis by stabilizing peroxisome proliferator-activated receptor alpha","volume":"300","author":"Liu","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"1\u20132","key":"10.1016\/j.bbadis.2026.168232_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11010-018-3368-y","article-title":"Silibinin-induced autophagy mediated by PPAR\u03b1-sirt1-AMPK pathway participated in the regulation of type I collagen-enhanced migration in murine 3T3-L1 preadipocytes","volume":"450","author":"Liu","year":"2019","journal-title":"Mol. Cell. Biochem."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926000955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926000955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:07:23Z","timestamp":1791202043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443926000955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0925443926000955"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168232","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"USP47 alleviates metabolic-associated fatty liver disease by activating the PPAR\u03b1 signaling pathway through the stabilization of SIRT1","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"168232"}}